NLBNPIT23FA4 20250321 38000 News - P23FA4 | Aktien Italienische Börse

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

- Statement of Beneficial Ownership (SC 13D)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. __ /*/) CHINA...

- Statement of Beneficial Ownership (SC 13D)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. __ /*/) CHINA...

- Statement of Beneficial Ownership (SC 13D)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. __ /*/) CHINA...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ___________ FORM 8-K ___________ CURRENT...

- Notification that Annual Report will be submitted late (NT 10-K)

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE...

China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results

-- 3Q09 Revenue Increases 43% Over Prior Year Third Quarter; Net Income Up Over 200%, Exceeding Company's Internal Projections -- GANSU, China...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR...

- Amended Quarterly Report (10-Q/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ...

China Dasheng Biotechnology Company (CDBT.OB) Pre-Announces Fiscal Year 2009 Second Quarter Earnings

-- Estimated FY Q2 2009 sales of $5.66 million increased 20.2% compared to FY Q2 2008. -- Estimated FY H1 2009 sales of $10.77 million increased...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ___________ FORM 8-K ___________ ...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ___________ FORM 8-K ___________ ...

- Amended Annual Report (10-K/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM 10-K [ x ] ANNUAL REPORT UNDER...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NLBNPIT23FA4 20250321 38000 (P23FA4)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

P23FA4 Nachrichten

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

- Statement of Beneficial Ownership (SC 13D)

- Statement of Beneficial Ownership (SC 13D)

- Statement of Beneficial Ownership (SC 13D)

- Current report filing (8-K)

- Notification that Annual Report will be submitted late (NT 10-K)

China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results

- Quarterly Report (10-Q)

- Amended Quarterly Report (10-Q/A)

- Quarterly Report (10-Q)

China Dasheng Biotechnology Company (CDBT.OB) Pre-Announces Fiscal Year 2009 Second Quarter Earnings

- Current report filing (8-K)

- Quarterly Report (10-Q)

- Current report filing (8-K)

- Amended Annual Report (10-K/A)

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NLBNPIT23FA4 20250321 38000 (P23FA4) News

NLBNPIT23FA4 20250321 38000 (P23FA4)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

P23FA4 Nachrichten

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

- Statement of Beneficial Ownership (SC 13D)

- Statement of Beneficial Ownership (SC 13D)

- Statement of Beneficial Ownership (SC 13D)

- Current report filing (8-K)

- Notification that Annual Report will be submitted late (NT 10-K)

China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results

- Quarterly Report (10-Q)

- Amended Quarterly Report (10-Q/A)

- Quarterly Report (10-Q)

China Dasheng Biotechnology Company (CDBT.OB) Pre-Announces Fiscal Year 2009 Second Quarter Earnings

- Current report filing (8-K)

- Quarterly Report (10-Q)

- Current report filing (8-K)

- Amended Annual Report (10-K/A)

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen